Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NeuroStar TMS Therapy System: Utilization and Outcomes
NCT01114477 · View on ClinicalTrials.gov ↗
Study Summary
The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
Conditions Studied
Study Locations (20)
California
- Bay Psychiatric Associates — Berkeley
- TMS Center of Beverly Hills — Beverly Hills
- Clinical Training & Research Institute — Burlingame
- Sacramento TMS — El Dorado Hills
- Martha Koo, MD — Hermosa Beach
- Orange County TMS Center — Laguna Hills
- Depression Research Center and Clinic-Semel Institute for Neuroscience & Human Behavior at UCLA — Los Angeles
- Kevin Kinback, MD — Mission Viejo
- Todd Hutton, MD & Associates — Pasadena
- The Botkiss Center for TMS Therapy — San Diego
- Stanford Hospital and Clinics — Stanford
- Arjun Reyes, MD — Woodland Hills
Connecticut
- Hartford Hospital — Hartford
- Comprehensive Psychiatric Care — Norwich
Florida
- Health Sciences America, LLC — Boca Raton
- Curtis Cassidy, MD — Lakeland
Arizona
- Lee Ann Kelley, M.D., PC — Phoenix
Delaware
- Christiana Care Health Services — Wilmington
Georgia
- Brian Teliho, MD — Atlanta
Illinois
- Carl M. Wahlstrom, Jr. MD Limited — Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114477
The ClinicalTrials.gov registry entry for NCT01114477 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 36 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01114477 reports 20 study locations spanning 7 distinct geographic areas — top geographies include California, Connecticut, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01114477 about?
NCT01114477 is a clinical study titled "NeuroStar TMS Therapy System: Utilization and Outcomes". The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
What is the current status of trial NCT01114477?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2010-03. Estimated completion is 2012-09.
What conditions does trial NCT01114477 study?
This clinical trial studies the following conditions: Major Depressive Disorder. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT01114477?
This trial is sponsored by Neuronetics, which has 36 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01114477 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.